Attenuation of reinstatement of methamphetamine-, sucrose-, and food-seeking behavior in rats by fenobam, a metabotropic glutamate receptor 5 negative allosteric modulator

[1]  Udo Albus,et al.  Book Review: Guide for the Care and use of Laboratory Animals , 1998 .

[2]  M. Olive,et al.  mGluR5 receptors in the basolateral amygdala and nucleus accumbens regulate cue-induced reinstatement of ethanol-seeking behavior , 2012, Pharmacology Biochemistry and Behavior.

[3]  A. Lawrence,et al.  The role of metabotropic glutamate receptors in addiction: Evidence from preclinical models , 2012, Pharmacology Biochemistry and Behavior.

[4]  P. Kalivas,et al.  Glutamatergic medications for the treatment of drug and behavioral addictions , 2012, Pharmacology Biochemistry and Behavior.

[5]  J. Witkin,et al.  mGlu5 receptor deletion reduces relapse to food-seeking and prevents the anti-relapse effects of mGlu5 receptor blockade in mice. , 2011, Life sciences.

[6]  M. Brecht,et al.  Methamphetamine: here we go again? , 2011, Addictive behaviors.

[7]  M. Olive,et al.  Differential Modulation of Thresholds for Intracranial Self-Stimulation by mGlu5 Positive and Negative Allosteric Modulators: Implications for Effects on Drug Self-Administration , 2011, Front. Pharmacol..

[8]  D. Rusyniak.  Neurologic manifestations of chronic methamphetamine abuse. , 2011, Neurologic clinics.

[9]  N. Volkow,et al.  New medications for drug addiction hiding in glutamatergic neuroplasticity , 2011, Molecular Psychiatry.

[10]  D. Ciccarone.  Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. , 2011, Primary care.

[11]  P. Rompré,et al.  Blockade of mGLUR5 receptors differentially alters amphetamine-induced enhancement of locomotor activity and of brain stimulation reward , 2011, Journal of psychopharmacology.

[12]  D. Sulzer,et al.  How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission , 2011, Neuron.

[13]  A. Weinstein,et al.  Pharmacological approaches to methamphetamine dependence: a focused review. , 2010, British journal of clinical pharmacology.

[14]  H. Schmidt,et al.  Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking , 2009, Behavioural Brain Research.

[15]  Robert W Gereau,et al.  The Metabotropic Glutamate Receptor Subtype 5 Antagonist Fenobam Is Analgesic and Has Improved in Vivo Selectivity Compared with the Prototypical Antagonist 2-Methyl-6-(phenylethynyl)-pyridine , 2009, Journal of Pharmacology and Experimental Therapeutics.

[16]  W. Jacob,et al.  The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning , 2009, Neuropharmacology.

[17]  Chris Cruickshank,et al.  A review of the clinical pharmacology of methamphetamine. , 2009, Addiction.

[18]  M. Olive,et al.  mGluR5 Antagonism Attenuates Methamphetamine Reinforcement and Prevents Reinstatement of Methamphetamine-Seeking Behavior in Rats , 2009, Neuropsychopharmacology.

[19]  P. Kalivas,et al.  Glutamate and reinstatement. , 2009, Current opinion in pharmacology.

[20]  D. Nguyen,et al.  A pilot open label, single dose trial of fenobam in adults with fragile X syndrome , 2009, Journal of Medical Genetics.

[21]  F. Tassone.  Newborn screening for fragile X syndrome. , 2008, JAMA neurology.

[22]  D. Nguyen,et al.  Trial of fenobam, an mGluR5 antagonist, in adults with Fragile X Syndrome , 2008 .

[23]  M. Olive,et al.  A Role for mGluR5 Receptors in Intravenous Methamphetamine Self‐Administration , 2008, Annals of the New York Academy of Sciences.

[24]  P. Halkitis,et al.  Methamphetamine Abuse in the United States , 2008, Journal of health psychology.

[25]  Stephen J. Kish,et al.  Pharmacologic mechanisms of crystal meth , 2008, Canadian Medical Association Journal.

[26]  R. Mcketin,et al.  Major physical and psychological harms of methamphetamine use. , 2008, Drug and alcohol review.

[27]  J. Maxwell,et al.  The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007. , 2008, Drug and alcohol review.

[28]  R. LaLumiere,et al.  Glutamate Release in the Nucleus Accumbens Core Is Necessary for Heroin Seeking , 2008, The Journal of Neuroscience.

[29]  W. Spooren,et al.  mGlu5 receptor antagonists and their therapeutic potential , 2008 .

[30]  I. Grant,et al.  Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis , 2007, Neuropsychology Review.

[31]  B. Yamamoto,et al.  Dynamic Changes in Vesicular Glutamate Transporter 1 Function and Expression Related to Methamphetamine-Induced Glutamate Release , 2007, The Journal of Neuroscience.

[32]  P. Hyytiä,et al.  Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats , 2007, Psychopharmacology.

[33]  W. Guba,et al.  Synthesis and biological evaluation of fenobam analogs as mGlu5 receptor antagonists. , 2007, Bioorganic & medicinal chemistry letters.

[34]  F. Vocci,et al.  Approaches to the development of medications for the treatment of methamphetamine dependence. , 2007, Addiction.

[35]  Y. Smith,et al.  Comparative analysis of the subcellular and subsynaptic localization of mGluR1a and mGluR5 metabotropic glutamate receptors in the shell and core of the nucleus accumbens in rat and monkey , 2007, The Journal of comparative neurology.

[36]  T. Koyama,et al.  Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine , 2006, Psychopharmacology.

[37]  Jens-Uwe Peters,et al.  Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity , 2005, Journal of Pharmacology and Experimental Therapeutics.

[38]  N. Cosford,et al.  Metabotropic Glutamate Receptor mGlu5 Is a Mediator of Appetite and Energy Balance in Rats and Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.

[39]  G. Koob,et al.  Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats , 2005, Psychopharmacology.

[40]  A. Markou,et al.  The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats , 2005, Psychopharmacology.

[41]  N. Volkow,et al.  Unmanageable Motivation in Addiction: A Pathology in Prefrontal-Accumbens Glutamate Transmission , 2005, Neuron.

[42]  P. Kenny,et al.  The ups and downs of addiction: role of metabotropic glutamate receptors. , 2004, Trends in pharmacological sciences.

[43]  F. Gasparini,et al.  Group II Metabotropic and α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionate (AMPA)/Kainate Glutamate Receptors Regulate the Deficit in Brain Reward Function Associated with Nicotine Withdrawal in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[44]  P. Kalivas,et al.  Brain circuitry and the reinstatement of cocaine-seeking behavior , 2003, Psychopharmacology.

[45]  S. D. Glick,et al.  Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats , 2003, Psychopharmacology.

[46]  A. Harrison,et al.  Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats , 2002, Psychopharmacology.

[47]  B. Everitt,et al.  Differential Involvement of NMDA, AMPA/Kainate, and Dopamine Receptors in the Nucleus Accumbens Core in the Acquisition and Performance of Pavlovian Approach Behavior , 2001, The Journal of Neuroscience.

[48]  F. Conquet,et al.  Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice , 2001, Nature Neuroscience.

[49]  J. Angulo,et al.  Comparison of Cocaine‐ and Methamphetamine‐Evoked Dopamine and Glutamate Overflow in Somatodendritic and Terminal Field Regions of the Rat Brain during Acute, Chronic, and Early Withdrawal Conditions , 2001, Annals of the New York Academy of Sciences.

[50]  A. Gardier,et al.  Effects of repeated systemic administration of d-Fenfluramine on serotonin and glutamate release in rat ventral hippocampus: comparison with methamphetamine using in vivo microdialysis , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[51]  P. Kalivas,et al.  Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction , 2000, The Journal of Neuroscience.

[52]  M D Anglin,et al.  History of the Methamphetamine Problem , 2000, Journal of psychoactive drugs.

[53]  B. Yamamoto,et al.  Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex , 1995, Brain Research.

[54]  A. N. van den Pol,et al.  Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain , 1995, The Journal of comparative neurology.

[55]  R. Duvoisin,et al.  The metabotropic glutamate receptors: Structure and functions , 1995, Neuropharmacology.

[56]  Shigetada Nakanishi,et al.  Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain , 1993, Neuroscience Letters.

[57]  J. Pecknold,et al.  Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study. , 1982, Journal of clinical psychopharmacology.

[58]  Oliver Mf.  Metabotropic glutamate receptor ligands as potential therapeutics for addiction. , 2009 .

[59]  M. Olive,et al.  Glutamatergic substrates of drug addiction and alcoholism. , 2008, Biochemical pharmacology.

[60]  J. Pin,et al.  Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.

[61]  A. Rowan.  Guide for the Care and Use of Laboratory Animals , 1979 .

[62]  B. Pitt.  Psychopharmacology , 1968, Mental Health.